F16IL2 in Combination With Nivolumab in Patients With Non-small Cell Lung Cancer
Clinical trial NCT05468294 · UNKNOWN
Trial details
- NCT number
- NCT05468294
- Sponsor
- Philogen S.p.A.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-09
- Primary completion
- 2021-12-31
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.